Cooper Companies (NASDAQ:COO) Raised to “Buy” at Wall Street Zen

Cooper Companies (NASDAQ:COO) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.

A number of other brokerages also recently weighed in on COO. The Goldman Sachs Group reissued a “sell” rating and set a $73.00 target price on shares of Cooper Companies in a research note on Friday, January 9th. Citigroup restated a “neutral” rating and set a $88.00 target price (up from $72.00) on shares of Cooper Companies in a research report on Monday, December 8th. Mizuho set a $100.00 target price on Cooper Companies and gave the stock an “outperform” rating in a research note on Friday, December 5th. Morgan Stanley boosted their price target on Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a research note on Monday, December 8th. Finally, Needham & Company LLC reduced their price objective on shares of Cooper Companies from $100.00 to $99.00 and set a “buy” rating for the company in a research report on Tuesday, February 3rd. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $90.77.

Cooper Companies Stock Down 0.4%

Shares of COO opened at $83.67 on Friday. The stock’s 50-day moving average price is $82.27 and its two-hundred day moving average price is $75.70. Cooper Companies has a 12 month low of $61.78 and a 12 month high of $92.84. The company has a market capitalization of $16.32 billion, a PE ratio of 44.51, a PEG ratio of 2.40 and a beta of 1.03. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same period last year, the company earned $1.04 earnings per share. The firm’s revenue was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, analysts anticipate that Cooper Companies will post 3.98 EPS for the current year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III acquired 10,000 shares of the stock in a transaction on Tuesday, December 16th. The shares were purchased at an average price of $80.80 per share, for a total transaction of $808,000.00. Following the completion of the acquisition, the chief executive officer owned 236,151 shares in the company, valued at approximately $19,081,000.80. This represents a 4.42% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Lawrence Erik Kurzius acquired 2,000 shares of the company’s stock in a transaction on Wednesday, December 17th. The stock was acquired at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the completion of the purchase, the director directly owned 7,777 shares of the company’s stock, valued at approximately $641,602.50. This represents a 34.62% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased a total of 16,014 shares of company stock worth $1,304,416 in the last ninety days. 1.98% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Cooper Companies

Hedge funds have recently added to or reduced their stakes in the stock. New York Life Investment Management LLC lifted its holdings in shares of Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after purchasing an additional 158 shares in the last quarter. Root Financial Partners LLC raised its position in Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares during the last quarter. Allworth Financial LP lifted its stake in Cooper Companies by 14.1% during the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after acquiring an additional 167 shares in the last quarter. Wealth Alliance LLC lifted its stake in Cooper Companies by 4.2% during the 2nd quarter. Wealth Alliance LLC now owns 4,230 shares of the medical device company’s stock valued at $301,000 after acquiring an additional 171 shares in the last quarter. Finally, Mesirow Financial Investment Management Inc. boosted its holdings in Cooper Companies by 1.3% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock worth $961,000 after acquiring an additional 175 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.